Need help finding what you are looking for?
Contact Us
PUBLISHER: The Business Research Company | PRODUCT CODE: 1402040
PUBLISHER: The Business Research Company | PRODUCT CODE: 1402040
AI In Pharma Global Market Opportunities And Strategies To 2032
PUBLISHED:
PAGES: 259 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
“AI In Pharma Market Opportunities and Strategies to 2032 ” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global AI in pharma market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Where is the largest and fastest-growing market for AI in pharma? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? “The AI in pharma market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider AI in pharma market; and compares it with other markets.
The report covers the following chapters:
- Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by drug type and by application market.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario - The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the AI in pharma market.
- Global Market Size And Growth - Global historic (2017-2022) and forecast (2022-2027, 2032F) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast.
- Regional Analysis - Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by technology, by drug type and by application in the market. Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region market.
- Regional Market Size And Growth - Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations - This section includes recommendations for AI in pharma providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
- 1) By Technology: Context-Aware Processing; Natural Language Processing; Querying Method; Deep Learning
- 2) By Drug Type: Small Molecule; Large Molecules
- 3) By Application: Diagnosis; Clinical Trial Research; Drug Discovery; Research And Development; Epidemic Prediction
- Companies Mentioned: Concerto HealthAI; Alphabet Inc; OWKIN; Nvidia Corporation and Path AI
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; AI in pharma indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Product Code: o&s1002
Table of Contents
1 Executive Summary
- 1.1 AI In Pharma - Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 AI In Pharma Market Definition And Segmentations
- 6.4 Market Segmentation By Technology
- 6.4.1 Context-Aware Processing
- 6.4.2 Natural Language Processing
- 6.4.3 Querying Method
- 6.4.4 Deep Learning
- 6.5 Market Segmentation By Drug Type
- 6.5.1 Small Molecule
- 6.5.2 Large Molecules
- 6.6 Market Segmentation By Application
- 6.6.1 Diagnosis
- 6.6.2 Clinical Trial Research
- 6.6.3 Drug Discovery
- 6.6.4 Research And Development
- 6.6.5 Epidemic Prediction
7 Major Market Trends
- 7.1 Introduction Of Generative AI In Pharma To Improve Medical Consultations
- 7.2 Use Of AI In Molecular Target Identification
- 7.3 Integration Of AI In Drug Screening Process To Accelerate Drug Development
- 7.4 Growing Investments To Develop New Product Solutions
- 7.5 Strategic Partnerships And Collaborations Among Market Players
8 AI In Pharma Market - Macro Economic Scenario
- 8.1 COVID-19 Impact On The AI In Pharma Market
- 8.2 Impact Of The War In Ukraine On The AI In Pharma Market
- 8.3 Impact Of High Inflation On The AI In Pharma Market
9 Global Market Size and Growth
- 9.1 Market Size
- 9.2 Historic Market Growth, 2017 - 2022, Value ($ Million)
- 9.2.1 Market Drivers 2017 - 2022
- 9.2.2 Market Restraints 2017 - 2022
- 9.3 Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
- 9.3.1 Market Drivers 2022 - 2027
- 9.3.2 Market Restraints 2022 - 2027
10 Global AI In Pharma Market Segmentation
- 10.1 Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 10.2 Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 10.3 Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
11 AI In Pharma Market, Regional and Country Analysis
- 11.1 Global AI In Pharma Market, By Region, Historic and Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 11.2 Global AI In Pharma Market, By Country, Historic and Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
12 Asia-Pacific Market
- 12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
- 12.2 Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.3 Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.4 Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.5 Asia-Pacific AI In Pharma Market: Country Analysis
- 12.6 China Market
- 12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
- 12.8 China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.9 China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.10 China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.11 India Market
- 12.12 India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.13 India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.14 India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.15 Japan Market
- 12.16 Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.17 Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.18 Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.19 Australia Market
- 12.20 Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.21 Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.22 Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.23 Indonesia Market
- 12.24 Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.25 Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.26 Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.27 South Korea Market
- 12.28 South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.29 South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 12.30 South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
13 Western Europe Market
- 13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate Tax Structure
- 13.1.11 Investments
- 13.1.12 Major Companies
- 13.2 Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.3 Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.4 Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.5 Western Europe AI In Pharma Market: Country Analysis
- 13.6 UK Market
- 13.7 UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.8 UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.9 UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.10 Germany Market
- 13.11 Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.12 Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.13 Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.14 France Market
- 13.15 France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.16 France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 13.17 France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
14 Eastern Europe Market
- 14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Investments
- 14.1.12 Major Companies
- 14.2 Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 14.3 Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 14.4 Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 14.5 Eastern Europe AI In Pharma Market: Country Analysis
- 14.6 Russia Market
- 14.7 Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 14.8 Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 14.9 Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
15 North America Market
- 15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
- 15.2 North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 15.3 North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 15.4 North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 15.5 North America AI In Pharma Market: Country Analysis
- 15.6 USA Market
- 15.7 Summary
- 15.7.1 Country Information
- 15.7.2 Market Information
- 15.7.3 Background Information
- 15.7.4 Government Initiatives
- 15.7.5 Regulations
- 15.7.6 Regulatory Bodies
- 15.7.7 Major Associations
- 15.7.8 Taxes Levied
- 15.7.9 Corporate Tax Structure
- 15.7.10 Investments
- 15.7.11 Major Companies
- 15.8 USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 15.9 USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 15.10 USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
16 South America Market
- 16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Investments
- 16.1.12 Major Companies
- 16.2 South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 16.3 South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 16.4 South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 16.5 South America AI In Pharma Market: Country Analysis
- 16.6 Brazil Market
- 16.7 Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 16.8 Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 16.9 Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
17 Middle East Market
- 17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
- 17.2 Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 17.3 Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 17.4 Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
18 Africa Market
- 18.1 Summary
- 18.1.1 Market Overview
- 18.1.2 Region Information
- 18.1.3 Market Information
- 18.1.4 Background Information
- 18.1.5 Government Initiatives
- 18.1.6 Regulations
- 18.1.7 Regulatory Bodies
- 18.1.8 Major Associations
- 18.1.9 Taxes Levied
- 18.1.10 Corporate Tax Structure
- 18.1.11 Investments
- 18.1.12 Major Companies
- 18.2 Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 18.3 Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
- 18.4 Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 - 2023, 2027F, 2032F, Value ($ Million)
19 Competitive Landscape And Company Profiles
- 19.1 Company Profiles
- 19.2 Concerto HealthAI
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
- 19.3 Alphabet Inc.
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
- 19.4 OWKIN
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
- 19.5 Nvidia Corporation
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
- 19.6 PathAI
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial Overview
20 Key Mergers And Acquisitions
- 20.1 BioNTech Acquired InstaDeep
- 20.2 Recursion Pharmaceuticals Acquired Cyclica And Valence
- 20.3 Telix Pharmaceuticals Acquired Dedicaid GmbH
- 20.4 Envision Pharma Group Acquired OKRA.ai
- 20.5 Bayer AG Acquired Blackford Analysis Ltd
- 20.6 iBio Acquired Rubryc Therapeutics
- 20.7 Genentech Acquired Prescient Design
- 20.8 Nurosene Health Inc Acquired Netramark Incorporated
- 20.9 X-Chem Acquired Glamorous AI
21 Opportunities And Strategies
- 21.1 Global AI In Pharma Market In 2027 - Countries Offering Most New Opportunities
- 21.2 Global AI In Pharma Market In 2027 - Segments Offering Most New Opportunities
- 21.3 Global AI In Pharma Market In 2027 - Growth Strategies
- 21.3.1 Market Trend Based Strategies
- 21.3.2 Competitor Strategies
22 AI In Pharma Market, Conclusions And Recommendations
- 22.1 Conclusions
- 22.2 Recommendations
- 22.2.1 Product
- 22.2.2 Place
- 22.2.3 Price
- 22.2.4 Promotion
- 22.2.5 People
23 Appendix
- 23.1 Geographies Covered
- 23.2 Market Data Sources
- 23.3 Research Methodology
- 23.4 Currencies
- 23.5 The Business Research Company
- 23.6 Copyright and Disclaimer
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.